pharmaceut focus next week
earn kick coverag week report
also expect addit gener cross-read nv iri data tue read
report tue call et dial-in id larg in-
line street attent instead focus long-term outlook look past
believ reason well-posit weather see near-term risk
hospital/anim busi potenti off-set vaccin demand also
expect continu focu keytruda ahead upcom competitor data read
report tue call et dial-in keep eye
promot sensit product like xeljanz vyndaqel eliqui given disrupt
otherwis expect fare reason well remain top defens name large-cap
also expect focu upjohn busi given china exposur recent delay viatri
deal close time
report thur call et dial-in id given pre-
announc surpris focu full year think expect
re-affirmed outlook see separ note even link also get look latest iri
data week end releas tue ahead earn remain
one top defens idea along also favor posit post pandem
report friday call et upgrad outperform last week one
top offens name link deal set close immin like set-up
near-term impact price share unlik get pro-forma guidanc
deal close like pro-forma ep remain focu closer look deal see
report deep dive bring pro-forma forecast outlook set-up
nv report thur call et nvs/sandoz provid earli read
gener sector recent host manag call glenmark link link nv
remain first tangibl data point updat also come follow break
deal aurobindo sell dermatology/or solid busi
virtual american associ cancer research annual meet take place
meet kick sever present could bring increment read
watch keytruda present nsclc includ post hoc analysi
initi phase result investig combin also
clinic data melanoma present could support
dose could meaning viral pandem
abstract titl releas virtual take place
watch abstract titl key nsclc trial bmy/azn week anticip
sever abstract titl read oncolog coverag particularli focus
present potenti azn read keytruda nsclc market
share present includ checkmat investig tripl regimen
chemotherapi potenti azn poseidon studi nsclc also host
oncolog event et
price prior trade day market close estimate unless otherwis note
valu usd unless otherwis note
capit market appreci consider institut investor all-america research survey
pharmaceut focus next week
analyst respons prepar research report receiv compens base upon variou factor includ
total revenu member compani capit market affili portion gener
invest bank activ member compani capit market affili
pleas note current conflict disclosur may differ public date set forth
report access current conflict disclosur client refer http //www rbccm com/gldisclosure/publicweb/
send request cm research publish bay street royal bank plaza
member compani capit market one affili manag co-manag public offer secur
abbvi inc past month
member compani capit market one affili receiv compens invest bank servic
abbvi inc past month
capit market llc make market secur abbvi inc
member compani capit market one affili receiv compens product servic
invest bank servic abbvi inc past month time member compani capit
market one affili provid non-secur servic abbvi inc
capit market current provid abbvi inc non-secur servic
capit market provid abbvi inc invest bank servic past month
capit market llc make market secur merck co inc
member compani capit market one affili receiv compens product servic
invest bank servic merck co inc past month time member compani capit
market one affili provid non-invest bank securities-rel servic merck co inc
capit market current provid merck co inc non-invest bank securities-rel servic
capit market provid merck co inc non-invest bank securities-rel servic past month
member compani capit market one affili manag co-manag public offer secur
inc past month
member compani capit market one affili receiv compens invest bank servic
pfizer inc past month
capit market llc make market secur pfizer inc
member compani capit market one affili receiv compens product servic
invest bank servic pfizer inc past month time member compani capit
market one affili provid non-secur servic pfizer inc
capit market current provid pfizer inc non-secur servic
capit market provid pfizer inc invest bank servic past month
capit market llc make market secur perrigo compani public limit compani
explan capit market equiti rate system
pharmaceut focus next week
analyst sector univers compani analyst provid research coverag accordingli rate assign
particular stock repres sole analyst view stock perform next month rel
outperform expect materi outperform sector averag month
sector perform sp return expect line sector averag month
under-perform return expect materi sector averag month
restrict polici preclud certain type commun includ invest recommend
act advisor certain merger strateg transact certain circumst
rate nr rate price target estim remov due applic legal regulatori polici constraint
may includ capit market act advisori capac involv compani
march capit market discontinu top pick rate top pick rate secur repres analyst best
idea sector expect provid signific absolut return month favor risk-reward ratio top pick
rate secur reassign outperform rate secur categori secur expect materi
outperform sector averag month
specul risk rate reflect secur lower level financi oper predict illiquid share trade volum
high balanc sheet leverag limit oper histori result higher expect financi and/or stock price volatil
distribut rate
purpos rate distribut regulatori rule requir member firm assign rate one three rate categori
 buy hold/neutr sell regardless firm rate categori although capit market rate outperform
sector perform sp under-perform close correspond buy hold/neutr sell respect mean
rate determin rel basi
distribut rate
rate price target histori abbvi inc us usd
tp top pick outperform sp sector perform under-perform restrict initi research coverag discontinu research coverag
nr rate na avail rl recommend list rl refer date secur place recommend list rl refer date
secur remov recommend list rtg rate
creat bluematrix
